MARKET

ISEE

ISEE

IVERIC bio Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.15
-0.39
-3.11%
After Hours: 12.15 +0.02 +0.16% 16:31 01/21 EST
OPEN
12.48
PREV CLOSE
12.54
HIGH
12.85
LOW
12.15
VOLUME
1.13M
TURNOVER
--
52 WEEK HIGH
19.32
52 WEEK LOW
4.960
MARKET CAP
1.39B
P/E (TTM)
-10.8793
1D
5D
1M
3M
1Y
5Y
BRIEF-Iveric Bio Announces Addition Of Christine Ann Miller, To Its Board Of Directors
reuters.com · 01/06 13:25
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, January 04, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.
Business Wire · 01/04 21:35
IVERIC bio (ISEE) is on the Move, Here's Why the Trend Could be Sustainable
Zacks.com · 01/04 00:39
Novavax (NVAX) COVID Jab Gets WHO Nod for Emergency Use Listing
Zacks.com · 01/02 00:21
bluebird's (BLUE) BLA for CALD Therapy Gets Priority Review
Zacks.com · 01/02 00:20
Glaxo (GSK) Gets FDA Nod for HIV Preventive Injectable Drug
Zacks.com · 01/02 00:20
BridgeBio (BBIO) Tumbles on Cardiomyopathy Candidate Failure
Zacks.com · 01/02 00:16
Jazz (JAZZ) Enrolls First Patient in Psychiatric Disorder Study
Zacks.com · 12/31/2021 14:33
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ISEE. Analyze the recent business situations of IVERIC bio Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ISEE stock price target is 23.75 with a high estimate of 26.00 and a low estimate of 22.00.
High26.00
Average23.75
Low22.00
Current 12.15
EPS
Actual
Estimate
-0.26-0.19-0.13-0.06
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 199
Institutional Holdings: 109.82M
% Owned: 95.79%
Shares Outstanding: 114.64M
TypeInstitutionsShares
Increased
62
21.29M
New
39
10.26M
Decreased
31
7.74M
Sold Out
18
5.24M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.82%
Pharmaceuticals & Medical Research
-1.11%
Key Executives
President
Pravin Dugel
Chief Executive Officer/Director
Glenn Sblendorio
Chief Financial Officer/Senior Vice President/Treasurer
David Carroll
Chief Operating Officer/Senior Vice President
Keith Westby
Executive Vice President
Anthony Gibney
Senior Vice President
Christopher Simms
Lead Director/Independent Director
Adrienne Graves
Director
Christine Miller
Independent Director
Mark Blumenkranz
Independent Director
Axel Bolte
Independent Director
Jane Henderson
Independent Director
Calvin Roberts
No Data
About ISEE
IVERIC bio, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of treatment options for retinal diseases. The Company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases (IRDs). The Company's therapeutics portfolio consists of Zimura (avacincaptad pegol), a complement C5 inhibitor, and IC-500, a high-temperature requirement A serine peptidase 1 protein (HtrA1) inhibitor. The Company's gene therapy portfolio consists of two product candidates in pre-clinical development, IC-100 and IC-200. The Company is developing IC-100 for rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for bestrophin-1 (BEST1) related IRDs.

Webull offers kinds of IVERIC bio Inc stock information, including NASDAQ:ISEE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISEE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISEE stock methods without spending real money on the virtual paper trading platform.